(NYSE: NGVT) Ingevity's forecast annual revenue growth rate of -2.58% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 2.58%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 8.2%.
Ingevity's revenue in 2024 is $1,548,400,000.On average, 2 Wall Street analysts forecast NGVT's revenue for 2024 to be $51,408,340,840, with the lowest NGVT revenue forecast at $50,992,189,330, and the highest NGVT revenue forecast at $51,824,492,349. On average, 2 Wall Street analysts forecast NGVT's revenue for 2025 to be $53,080,215,900, with the lowest NGVT revenue forecast at $51,900,817,080, and the highest NGVT revenue forecast at $54,259,614,719.
In 2026, NGVT is forecast to generate $55,898,779,180 in revenue, with the lowest revenue forecast at $55,898,779,180 and the highest revenue forecast at $55,898,779,180.